Novel antitumor and neuroprotective substances discovered by characteristic screenings based on specific molecular targets

Bioscience, Biotechnology and Biochemistry

Volumn 69, Issue 5, 2005, Pages 867-872

  Shin Ya, Kazuo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

G quadruplex; Glutamate receptor; Molecular chaperone; Telomerase

Indexed keywords

BRAIN; CALCIUM; CHARACTERIZATION; DNA; POSITIVE IONS; TOXICITY; TUMORS;

CHAPERONE; KAITOCEPHALIN; TELOMESTATIN; VERSIPELOSTATIN;

ENZYMES;

ANTINEOPLASTIC AGENT; CHAPERONE; GLUTAMATE RECEPTOR; HEAT SHOCK PROTEIN; KAITOCEPHALIN; MACROLIDE; MOLECULAR CHAPERONE GRP78; NEUROPROTECTIVE AGENT; OLIGOSACCHARIDE; OXAZOLE DERIVATIVE; PYRROLE DERIVATIVE; TELOMERASE; TELOMESTATIN; VERSIPELOSTATIN;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; HUMAN; REVIEW;

ANTINEOPLASTIC AGENTS; GENE EXPRESSION; HEAT-SHOCK PROTEINS; HUMANS; MACROLIDES; MOLECULAR CHAPERONES; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; OLIGOSACCHARIDES; OXAZOLES; PYRROLES; RECEPTORS, GLUTAMATE; TELOMERASE;

EID: 22444447447     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.69.867     Document Type: Review

References (20)

1. Shin-ya, K., Wierzba, K., Matsuo, K., Ohtani, T., Yamada, Y., Furihata, K., Hayakawa, Y., and Seto, H., Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J. Am. Chem. Soc., 123, 1262-1263 (2001).
2. Park, H.-R., Furihata, K., Hayakawa, Y., and Shin-ya, K., Versipelostatin, a novel GRP78/Bip molecular chaperone down-regulator of microbial origin. Tetrahedron Lett., 43, 6941-6945 (2002).
3. Shin-ya, K., Kim, J.-S., Furihata, K., Hayakawa, Y., and Seto, H., Structure of kaitocephalin, a novel glutamate receptor antagonist produced by Eupenicillium shearii. Tetrahedron Lett., 38, 7079-7082 (1997).
4. Kobayashi, H., Shin-ya, K., Furihata, K., Hayakawa, Y., and Seto, H., Absolute configuration of a novel glutamate receptor antagonist kaitocephalin. Tetrahedron Lett., 42, 4021-4023 (2001).
5. Okue, M., Kobayashi, H., Furihata, K., Hayakawa, Y., Seto, H., Watanabe, H., and Kitahara, T., Synthesis of the proposed structure and revision of stereochemistry of kaitocephalin. Tetrahedron Lett., 43, 857-860 (2002).
6. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W., Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015 (1994).
7. Naasani, I., Seimiya, H., Yamori, T., and Tsuruo, T., FJ5002: A potent telomerase inhibitor identified by exploiting the Disease-Oriented Screening program with COMPARE analysis. Cancer Res., 59, 4004-4011 (1999).
8. Rha, S. Y., Izbicka, E., Lawrence, R., Davidson, K., Sun, D., Moyer, M. P., Roodman, G. D., Hurley, L. H., and Von Hoff, D., Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Clin. Cancer Res., 6, 987-993 (2000).
9. Neidle, S., and Parkinson, G., Telomere maintenance as a target for anticancer drug discovery. Nat. Rev. Drug Discov., 1, 383-393 (2002).
10. Parkinson, G. N., Lee, M. P. H., and Neidle, S., Crystal structure of parallel quadruplexes from human telomeric DNA. Nature, 417, 876-880 (2002).
11. Kim, M.-Y., Vankayalapati, H., Shin-ya, K., Wierzba, K., and Hurley, L. H., Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J. Am. Chem. Soc., 124, 2089-2099 (2002).
12. Smogorzewska, A., and de Lange, T., Different telomere damage signaling pathways in human and mouse cells. EMBO J., 21, 4338-4348 (2002).
13. Tauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Nakajima, A., Shimamoto, T., Ohyashiki, J. H., and Ohyashiki, K., Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: Involvement of ATM-dependent DNA damage response pathways. Oncogene, 22, 5338-5347 (2003).
14. Ogiso, Y., Tomida, A., Lei, S., Omura, S., and Tsuruo, T., Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs. Cancer Res., 60, 2429-2434 (2000).
15. Park, H.-R., Tomida, A., Sato, S., Tsukumo, Y., Yun, J., Yamori, T., Hayakawa, Y., Tsuruo, T., and Shin-ya, K., Blockade of survival response to glucose deprivation for selective killing of tumor cells. J. Natl. Can. Inst., 96, 1300-1330 (2004).
16. Pahl, H. L., and Baeuerle, P. A., A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J., 14, 2580-2588 (1995).
17. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., and Mori, H., XBP1 mRNA ix induced by ATF6 and spliced by Ire1 in response to ER stress to produce a highly active transcription factor. Cell, 107, 881-891 (2001).
18. Urano, F., Bertolotti, A., and Ron, D., IRE1 and efferent signaling from the endoplasmic reticulum. J. Cell Sci., 113, 3697-3702 (2000).
19. Choi, D. W., Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci., 11, 465-469 (1988).
20. Sheardown, M. J., Nielsen, E. O., Hansen, A. J., Jacobsen, P., and Honore, T., 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science, 247, 571-574 (1990).